SC
OFIX icon

Stephens Consulting’s Orthofix Medical OFIX Stock Holding History

Stephens Consulting’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$408 – 1731
2025
Q1 		$408 Buy
+25
New +$439 ﹤0.01% 1016

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
AYAL Capital Advisors Toronto, Ontario, Canada $370M AUM 52.93% 1-Year Est. Return

Stephens Consulting's OFIX Position: Q2 2025 in Review

Stephens Consulting sold out of Orthofix Medical (OFIX) in Q2 2025, closing a stake of 25 shares — an estimated $408 sold.

Stephens Consulting first reported a position in OFIX in Q1 2025 and held it in 1 quarter. The position peaked at $408 in Q1 2025. 158 funds tracked by Wall St. Rank hold OFIX as of Q2 2025.

  • Stephens Consulting reported no remaining Orthofix Medical position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 25 Orthofix Medical shares in Q2 2025, an estimated $408.
  • Stephens Consulting first reported a position in Orthofix Medical in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's Orthofix Medical position peaked at $408 in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.